Literature DB >> 9183281

Pearls, pitfalls, and updates for pain management.

J J Martin1, G P Moore.   

Abstract

Pain management is one of the most challenging areas we encounter as emergency physicians. However, many of us fail to adequately meet this challenge. This article discusses frequently encountered pain syndromes and pain management options.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9183281     DOI： 10.1016/s0733-8627(05)70307-2

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN： 0733-8627            Impact factor:   2.264


  5 in total

1.  Differences in Sensory Pain, Expectation, and Satisfaction Reported by Outpatients with Cancer or Sickle Cell Disease.

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Brenda Dyal; Khulud Abudawood; Diana J Wilkie
Journal:  Pain Manag Nurs       Date:  2018-03-01       Impact factor: 1.929

2.  Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.

Authors:  Diana J Wilkie; Robert Molokie; Debra Boyd-Seal; Marie L Suarez; Young Ok Kim; Shiping Zong; Harriet Wittert; Zhongsheng Zhao; Yogen Saunthararajah; Zaijie J Wang
Journal:  J Natl Med Assoc       Date:  2010-01       Impact factor: 1.798

3.  Sickle cell disease: an opportunity for palliative care across the life span.

Authors:  Diana J Wilkie; Bonnye Johnson; A Kyle Mack; Richard Labotka; Robert E Molokie
Journal:  Nurs Clin North Am       Date:  2010-09       Impact factor: 1.208

4.  Outpatient management of sickle cell pain with chronic opioid pharmacotherapy.

Authors:  Lauren Shaiova; David Wallenstein
Journal:  J Natl Med Assoc       Date:  2004-07       Impact factor: 1.798

5.  Outcomes of multidisciplinary team interventions in the management of sickle cell disease patients with opioid use disorders. A retrospective cohort study.

Authors:  Omar Al Zahrani; Ehab Hanafy; Osama Mukhtar; Ashraf Sanad; Wael Yassin
Journal:  Saudi Med J       Date:  2020-10       Impact factor: 1.484
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.